Jilin Jian Yisheng Pharmaceutical Co., Ltd. (SHE:002566)

SHE:002566 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Cash & Equivalents	85.14	63.55	71.48	487.73	343.26	219.7
Short-Term Investments	-	-	-	-	-	30.08
Trading Asset Securities	513.26	507.57	459.67	102.98	59.84	70.16
Cash & Short-Term Investments	598.4	571.13	531.15	590.72	403.11	319.94
Cash Growth	5.00%	7.53%	-10.08%	46.54%	25.99%	11.48%
Accounts Receivable	238.59	214.89	199.03	198.53	264	254.84
Other Receivables	23.3	14.76	10.53	11.75	22.23	39.61
Receivables	261.9	230.96	209.56	210.28	286.23	294.45
Inventory	1,559	1,581	1,626	1,617	1,603	1,597
Other Current Assets	12.27	14.7	8.58	13.32	10.17	10.53
Total Current Assets	2,432	2,398	2,376	2,431	2,303	2,222
Property, Plant & Equipment	392.53	417.13	450.34	483.66	526.11	501.49
Long-Term Investments	-	15.6	15.23	-	-	-
Goodwill	1.91	1.91	1.91	1.91	1.91	1.91
Other Intangible Assets	106.65	108.66	111.35	114.18	117.03	119.96
Long-Term Deferred Tax Assets	20.41	15.85	13.15	12.62	14.2	15.2
Long-Term Deferred Charges	1.1	1.54	2.15	2.02	3.07	2.99
Other Long-Term Assets	16.48	1.13	0.76	1.27	1.68	1.04
Total Assets	2,971	2,960	2,971	3,047	2,967	2,864

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Accounts Payable	8.24	11.69	13	24.86	24.33	19.81
Accrued Expenses	6.22	22.41	22.26	32.51	30.68	48.11
Short-Term Debt	328.22	308.23	290.28	470.43	430.43	397.86
Current Portion of Long-Term Debt	3.09	0.3	0.42	-	-	2.55
Current Portion of Leases	-	2.4	2.98	2.34	3.29	3.31
Current Income Taxes Payable	4.98	0.14	0.01	2.78	0.64	5.55
Current Unearned Revenue	11.8	14.77	5.49	11.01	24.51	16.72
Other Current Liabilities	43.48	24.17	31.55	45.91	74.29	39.84
Total Current Liabilities	406.03	384.1	366	589.85	588.16	533.75
Long-Term Debt	129.6	129.7	149.7	-	-	-
Long-Term Leases	4.15	5.34	6.21	4.03	9.82	11.46
Long-Term Unearned Revenue	106.45	108.87	112.54	118.69	118.02	120.85
Long-Term Deferred Tax Liabilities	1.05	2.34	2.77	1.74	1.17	0.02
Total Liabilities	647.28	630.35	637.22	714.3	717.18	666.08

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Common Stock	330.95	330.95	330.95	330.95	330.95	330.95
Additional Paid-In Capital	834.69	834.69	834.69	834.69	834.69	834.69
Retained Earnings	1,061	1,066	1,070	1,068	989.34	916.17
Total Common Equity	2,226	2,232	2,236	2,233	2,155	2,082
Minority Interest	97.1	97.76	97.83	99.26	94.45	116.47
Shareholders' Equity	2,323	2,329	2,333	2,332	2,249	2,198
Total Liabilities & Equity	2,971	2,960	2,971	3,047	2,967	2,864

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Total Debt	465.07	445.97	449.59	476.8	443.55	415.18
Net Cash (Debt)	133.34	125.16	81.56	113.92	-40.44	-95.24
Net Cash Growth	60.99%	53.45%	-28.40%	-	-	-
Net Cash Per Share	0.40	0.38	0.25	0.34	-0.12	-0.29
Filing Date Shares Outstanding	330.84	330.95	330.95	330.95	330.95	330.95
Total Common Shares Outstanding	330.84	330.95	330.95	330.95	330.95	330.95
Working Capital	2,026	2,014	2,010	1,841	1,714	1,688
Book Value Per Share	6.73	6.74	6.76	6.75	6.51	6.29
Tangible Book Value	2,118	2,121	2,122	2,117	2,036	1,960
Tangible Book Value Per Share	6.40	6.41	6.41	6.40	6.15	5.92
Buildings	-	548.36	548.14	548.14	545.7	400.71
Machinery	-	352.2	353.49	359	357.13	321.57
Construction In Progress	-	-	-	-	1.98	119.32

Data Source: S&P Global Market Intelligence Last updated: Oct 26, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 2, 2026

Data Sources Report a data error